For example, overexpression of CCT2 could promote triple-negative breast cancer cell chemoresistance and cell migration and invasion via the AKT/GSK3β/β-catenin and XIAP/Survivin pathways (26). This evidence concerns the gene GSK3B and triple-negative breast carcinoma.